Skip to main content

Advertisement

SpringerLink
Log in

Parkinson’s disease and fatigue

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Fatigue is one of the most common symptoms in patients with Parkinson’s disease (PD), and its impact on the quality of life is substantial. However, its cause and treatment are not established. Fatigue in PD has two components, peripheral and central, which may be related to each other, but are more likely independent. Fatigue is partially associated with depression or sleep disorders, but patients with fatigue are not always depressed and do not necessarily have sleep problems. Anti-PD drugs may exacerbate or reduce fatigue. The impact of fatigue in PD is often underestimated by health-care providers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abe K, Takanashi M, Yanagihara T (2000) Fatigue in patients with Parkinson’s disease. Behav Neurol 12:103–106

    PubMed  Google Scholar 

  2. Abe K, Takanashi M, Yanagihara T et al. (2001–2002) Pergolide mesilate may improve fatigue in patients with Parkinson’s disease. Behav Neurol 13:117–121

    PubMed  Google Scholar 

  3. Abudi S, Bar-Tal Y, Ziv L et al. (1997) Parkinson’s disease symptoms—patient’s perception. J Adv Nurs 25:54–59

    Article  PubMed  CAS  Google Scholar 

  4. Boer AG, Wijker W, Speelman JD et al. (1996) Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 61:70–74

    Article  PubMed  Google Scholar 

  5. Brown RG, Dittner A, Findley L et al. (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11:49–55

    Article  PubMed  CAS  Google Scholar 

  6. Burn DJ (2002) Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson’s disease. Mov Disord 17:445–454

    Article  PubMed  Google Scholar 

  7. Cathebras PJ, Robbins JM, Kirmayer LJ et al. (1992) Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Int Med 7:276–286

    CAS  Google Scholar 

  8. Chalder T, Berelowitz G, Pawlikowska T et al. (1993) Development of a fatigue scale. J Psychosom Res 37:147–153

    Article  PubMed  CAS  Google Scholar 

  9. Chaudhuri A, Behan PO (2000) Fatigue and basal ganglia. J Neurol Sci 179:34–42

    Article  PubMed  CAS  Google Scholar 

  10. David A, Pelosi A, McDonald E et al. (1990) Tired, weak, or in need of rest: fatigue among general practice attenders. Br Med J 301:1199–1202

    CAS  Google Scholar 

  11. Davis JM (1995) Central and peripheral factors in fatigue. J Sports Sci 13:S49–S53

    PubMed  Google Scholar 

  12. Davis JM, Bailey SP (1997) Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 29:45–47

    PubMed  CAS  Google Scholar 

  13. Dooneief G, Mirabello E, Bell K, et al. 81992) An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch Neurol 49:305–307

    PubMed  CAS  Google Scholar 

  14. Ford H, Trigwell P, Johnson M (1998) The nature of fatigue in multiple sclerosis. J Psychosom Res 45:33–38

    Article  PubMed  CAS  Google Scholar 

  15. Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135–138

    PubMed  CAS  Google Scholar 

  16. Friedman J, Friedman H (1993) Fatigue in Parkinson’s disease. Neurology 43:2016–2108

    PubMed  CAS  Google Scholar 

  17. Friedman JH, Friedman H (2001) Fatigue in Parkinson’s disease: a nine-year follow-up. Mov Disord 6:1120–1122

    Article  Google Scholar 

  18. Fulcher KY, White PD (1997) Randomized controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br Med J 314:1647–1652

    CAS  Google Scholar 

  19. Funkiewiez A, Ardouin C, Krack P et al. (2003) Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease. Mov Disord 18:524–530

    Article  PubMed  Google Scholar 

  20. Garber CE, Friedman JH (2003) Effects of fatigue on physical activity and function in patients with Parkinson’s disease. Neurology 60:1119–1124

    PubMed  Google Scholar 

  21. Gillson G, Richard TL, Smith RB et al. (2002) A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis. Mult Scler 8:30–35

    Article  PubMed  CAS  Google Scholar 

  22. Herlofson K, Larsen JP (2003) The influence of fatigue on health-related quality of life in patients with Parkinson’s disease. Acta Neurol Scand 107:1–6

    Article  PubMed  CAS  Google Scholar 

  23. Hilten JJ, Weggeman M, van der Velde EA et al. (1993) Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm (P-D Sect) 5:235–244

    Article  Google Scholar 

  24. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    Article  PubMed  CAS  Google Scholar 

  25. Hwang WJ, Lin TS (2001) Evaluation of fatigue in Parkinson’s disease patients with stimulated single fiber electromyography. Acta Neurol Scand 104:271–274

    Article  PubMed  CAS  Google Scholar 

  26. Karlsen K, Larsen JP, Tandberg E et al. (1999) Fatigue in patients with Parkinson’s disease. Mov Disord 14:237–241

    Article  PubMed  CAS  Google Scholar 

  27. Kirk J, Douglass R, Nelson E et al. (1990) Chief complaint of fatigue: a prospective study. J Fam Practice 30:33–39

    CAS  Google Scholar 

  28. Kroenke K, Wood DR, Mangelsdorff AD et al. (1988) Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA 260:929–934

    Article  PubMed  CAS  Google Scholar 

  29. Krupp LB, LaRocca NG, Muir-Nash J et al. (1989) The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123

    PubMed  CAS  Google Scholar 

  30. Krupp LB, Pollina DA (1996) Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 9:456–460

    Article  PubMed  CAS  Google Scholar 

  31. Levi S, Cox M, Lugon M et al. (1990) Increased energy expenditure in Parkinson’s disease. Br Med J 301:1256–1257

    Article  CAS  Google Scholar 

  32. Loge JH, Ekeberg O, Kaasa S (1998) Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45:53–65

    Article  PubMed  CAS  Google Scholar 

  33. Lou JS, Benice T, Kearns G et al. (2003) Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson’s disease. Clin Neurophysiol 114:930–937

    Article  PubMed  CAS  Google Scholar 

  34. Lou JS, Kearns G, Oken B et al. (2001) Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Mov Disord 16:190–196

    Article  PubMed  CAS  Google Scholar 

  35. Marek T, Noworol G, Karwowski W (1998) Mental fatigue at work and pain perception. Work Stress 2:133–137

    Google Scholar 

  36. Markus HS, Cox M, Tomkins AM (1992) Raised resting energy expenditure in Parkinson’s disease and its relationship to muscle rigidity. Clin Sci 83:199–204

    PubMed  CAS  Google Scholar 

  37. Merkies IS, Schmitz PI, Samijn JP et al. (1999) Fatigue in immune-mediated polyneuropathies. Europian Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53:1648–1654

    PubMed  CAS  Google Scholar 

  38. Mock V, Atkinson A, Barsevick A et al. (2000) NCCN practice guidelines for cancer-related fatigue. Oncology 14:151–161

    PubMed  CAS  Google Scholar 

  39. Mostert S, Kesselring J (2002) Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 8:161–168

    Article  PubMed  CAS  Google Scholar 

  40. Peto V, Jenkinson C, Fitzpatrick R et al. (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248

    Article  PubMed  CAS  Google Scholar 

  41. Pogarell O, Gasser T, van Hilen JJ et al. (2002) Pramipexole in patients with Parkinson’s disease and marked drug resistant tremor: a randomized, double blind, placebo controlled multicentre study. J Neurol Neurosurg Psychiatry 72:713–720

    Article  PubMed  CAS  Google Scholar 

  42. Portenoy RK, Itri LM (1999) Cancerrelated fatigue: guidelines for evaluation and management. The Oncologist 4:1–10

    PubMed  CAS  Google Scholar 

  43. Robb-Nicholson LC, Daltroy L, Eaton H et al. (1989) Effect of aerobic conditioning in lupus fatigue: a pilot study. Br J Rheumatol 28:500–505

    PubMed  CAS  Google Scholar 

  44. Roelcke U, Kappos L, Lechner-Scott J et al. (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48:1566–1571

    PubMed  CAS  Google Scholar 

  45. Rossini PM, Pasqualetti P, Pozzilli C et al. (2001) Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Multi Scler 7:354–358

    Article  CAS  Google Scholar 

  46. Schenkman M, Wei Zhu C, Cutson TM et al. (2001) Longitudinal evaluation of economic and physical impact of Parkinson’s disease. Parkinsonism Relat Disord 8:41–50

    Article  PubMed  CAS  Google Scholar 

  47. Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312

    Article  PubMed  CAS  Google Scholar 

  48. Schrag A, Jahanshahi M, Quinn NP (2001) What contributes to depression in Parkinson’s disease? Psychol Med 31:65–73

    Article  PubMed  CAS  Google Scholar 

  49. Schwab RS, England AC, Peterson C (1959) Akinesia in Parkinson’s disease. Neurology 9:65–72

    PubMed  CAS  Google Scholar 

  50. Schwartz A (1998) The Schwartz cancer fatigue scale: testing reliability and validity. Oncol Nurs Forum 25:711–717

    PubMed  CAS  Google Scholar 

  51. Schwartz JE, Jandorf L, Krupp LB (1993) The measurement of fatigue: a new instrument. J Psychosom Res 37:753–762

    Article  PubMed  CAS  Google Scholar 

  52. Shulman LM, Taback RL, Bean J et al. (2001) Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 16:507–510

    Article  PubMed  CAS  Google Scholar 

  53. Smets EM, Garssen B, Bonke B et al. (1995) The Multidimensional Fatigue Inventry (MFI) psychosomatic qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325

    Article  PubMed  CAS  Google Scholar 

  54. Swain MG (2000) Fatigue in chronic disease. Clin Sci 99:1–8

    Article  PubMed  CAS  Google Scholar 

  55. Tandberg E, Larsen JP, Aarsland D et al. (1996) The occurrence of depression in Parkinson’s disease. A community-based study. Arch Neurol 53:175–179

    PubMed  CAS  Google Scholar 

  56. Taus C, Giuliani G, Pucci E et al. (2003) Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2:CD002818

    PubMed  Google Scholar 

  57. Tavio M, Milan I, Tirelli U (2002) Cancer-related fatigue (review). Int J Oncol 21:1093–1099

    PubMed  Google Scholar 

  58. Tolson D, Fleming V, Schartau E (2002) Coping with menstruation: understanding the needs of woman with Parkinson’s disease. J Adv Nurs 40:513–521

    Article  PubMed  Google Scholar 

  59. Vercoulen JH, Swanink CM, Galama JM et al. (1998) The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 45:507–517

    Article  PubMed  CAS  Google Scholar 

  60. Wang B, Gladman DD, Urowitz MB (1998) Fatigue in lupus is not correlated with disease activity. J Rheumatol 25:892–895

    PubMed  CAS  Google Scholar 

  61. Weinshenker BG, Penman M, Bass B et al. (1992) A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 42:1468–1471

    PubMed  CAS  Google Scholar 

  62. Ziv I, Avraham M, Michaelov Y et al. (1998) Enhanced fatigue during motor performance in patients with Parkinson’s disease. Neurology 51:1583–1586

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan

    Fumihito Yoshii MD, Hirohide Takahashi MD, Ryuya Kumazawa MD & Satoko Kobori MD

Authors
  1. Fumihito Yoshii MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hirohide Takahashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryuya Kumazawa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoko Kobori MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fumihito Yoshii MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshii, F., Takahashi, H., Kumazawa, R. et al. Parkinson’s disease and fatigue. J Neurol 253 (Suppl 7), vii48–vii53 (2006). https://doi.org/10.1007/s00415-006-7011-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-7011-6

Key words

Search

Navigation